Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin.
- Mechanism
- Curator reviewed · 1 reference
Oxaliplatin undergoes nonenzymatic conversion in physiologic solutions to active derivatives via displacement of the labile oxalate ligand. Several transient reactive species are formed, including monoaquo and diaquo DACH platinum, which covalently bind with macromolecules. Both inter and intrastrand Pt-DNA crosslinks are formed. Crosslinks are formed between the N7 positions of two adjacent guanines (GG), adjacent adenine-guanines (AG), and guanines separated by an intervening nucleotide (GNG). These crosslinks inhibit DNA replication and transcription. Cytotoxicity is cell-cycle nonspecific.
- Primary indication
- Oxaliplatin, in combination with infusional fluorouracil and leucovorin, is indicated for the treatment of advanced colorectal cancer and adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary...Curator reviewed · 3 structured indications
- Formula / weight
- C8H14N2O4Pt · 397.294 g/mol (avg)
- First approval
- Canada, 2007 · United States, 2002
- Also known as
- (SP-4-2-(1R-TRANS))-(1,2-CYCLOHEXANEDIAMINE-N,N')(ETHANEDIOATO(2-)-O,O')PLATINUM · Diaminocyclohexane Oxalatoplatinum · L-OHP · LOHP · Oxalatoplatin
- Code names
- JM-83 · L01XA03 · NSC-266046 · RP-54780 · SR-96669
Resolves to
ZROHGHOFXNOHSO-BNTLRKBRSA-LSMILES[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1What you can answer from here — as of September 20, 2026
Which other approved drugs treat the same conditions as Oxaliplatin, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account